Sutent and disease progression 
Sutent and disease progression Patient Reports February 11, 2012
Sutent Side Effects Report #5971276-4
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 24, 2008. Male patient, weighting 196.0 lb, was diagnosed with transitional cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, dizziness
, haematemesis, melaena, transitional cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with NORVASC, XALATAN, TAMSULOSIN, VICODIN, VITAMIN B6, METOPROLOL TARTRATE, VIAGRA, IBUPROFEN. Patient was hospitalized. Patient died on 11/01/2008.Sutent Side Effects Report #5141006-7
Sutent side effect was reported by a Physician from SWITZERLAND on Oct 13, 2006. Male patient, 45 years of age, weighting 154.3 lb, was diagnosed with synovial sarcoma metastatic, pneumonia bacterial and was treated with Sutent. After drug was administered, patient experienced the following side effects: acute hepatic failure, disease progression, haemodialysis, lactic acidosis, metabolic acidosis, pneumonia bacterial, subacute hepatic failure. Sutent dosage: 37.5 MG (37.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with CIPROFLOXACIN, DALFALGAN, AUGMENTIN, ZOLPIDEM TARTRATE. Patient died on 10/01/2006.
Sutent Side Effects Report #5146335-9
Sutent side effect was reported by a Physician from FRANCE on Oct 23, 2006. Female patient, 36 years of age, weighting 119.0 lb, was diagnosed with squamous cell carcinoma, neoplasm and was treated with Sutent. After drug was administered, patient experienced the following side effects: anaemia, disease progression, neutropenia, pleural effusion, thrombocytopenia, tumour haemorrhage. Sutent dosage: 25 MG (25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5418722-2
Sutent side effect was reported by a Physician from AUSTRALIA on Aug 06, 2007. Male patient, weighting 187.4 lb, was diagnosed with spinal cord compression and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, disease progression, neoplasm malignant, sensory loss. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5321761-3
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Female patient, weighting 178.6 lb, was diagnosed with retroperitoneal cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, retroperitoneal cancer. Sutent dosage: unknown. During the same period patient was treated with CAPECITABINE, COZAAR, ZOLOFT, RESTORIL, ASCORBIC ACID, IRON SULPHATETHIAMIN COMPOUND, LEVOTHYROXINE, COLACE. Patient died on 02/11/2007.
Sutent Side Effects Report #5618973-8
Sutent side effect was reported by a Physician from AUSTRALIA on Jan 29, 2008. Female patient, 81 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion, renal cell carcinoma, urinary tract infection
. Sutent dosage: unknown. During the same period patient was treated with CARDIZEM. Patient died on 01/01/2008.Sutent Side Effects Report #5761711-9
Sutent side effect was reported by a Health Professional from UNITED STATES on May 27, 2008. Female patient, 59 years of age, weighting 141.1 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: abdominal pain
, disease progression, intestinal perforation, pneumatosis intestinalis. Sutent dosage: unknown. Patient recovered.Sutent Side Effects Report #5930165-1
Sutent side effect was reported by a Physician from ARGENTINA on Oct 14, 2008. Female patient, 48 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hepatic function abnormal, jaundice
, renal cell carcinoma. Sutent dosage: DAILY DOSE:50MG. Patient recovered.Sutent Side Effects Report #5938035-X
Sutent side effect was reported by a Physician from ARGENTINA on Oct 21, 2008. Female patient, 48 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hepatic function abnormal, jaundice
, renal cell carcinoma. Sutent dosage: DAILY DOSE:50MG. Patient recovered.Sutent Side Effects Report #5955530-8
Sutent side effect was reported by a Physician from ARGENTINA on Nov 05, 2008. Female patient, 48 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: acute abdomen, disease progression, hepatic enzyme increased, intestinal perforation, jaundice
, renal cell carcinoma. Sutent dosage: DAILY DOSE:50MG. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5964355-9
Sutent side effect was reported by a Physician from ARGENTINA on Nov 12, 2008. Female patient, 48 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hepatic function abnormal, intestinal perforation, jaundice
, renal cell carcinoma. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5974853-X
Sutent side effect was reported by a Physician from ARGENTINA on Nov 25, 2008. Female patient, 48 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hepatic function abnormal, intestinal perforation, jaundice
, renal cell carcinoma. Sutent dosage: DAILY DOSE:50MG-FREQ:4 WEEKS ON + 2 WEEKS OFF. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #6107677-3
Sutent side effect was reported by a Physician from UNITED STATES on Mar 06, 2009. Male patient, 47 years of age, weighting 176.0 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac disorder, cardiac failure, condition aggravated, coronary artery disease , coronary artery thrombosis, disease progression, ejection fraction decreased, electrocardiogram change. Sutent dosage: 37.5-50 MG QD 28D, 14D OFF ORAL. During the same period patient was treated with HEPARIN, PROTONIX, AMPICILLIN, GENTAMICIN, DITROPAN. Patient recovered.Sutent Side Effects Report #5676343-0
Sutent side effect was reported by a Consumer or non-health professional from PERU on Mar 11, 2008. Male patient, 46 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: unknown. Patient died on 02/17/2008.
Sutent Side Effects Report #5657419-0
Sutent side effect was reported by a Physician from JAPAN on Dec 27, 2007. Male patient, 24 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: convulsion, dehydration, disease progression, disseminated intravascular coagulation, epistaxis, eyelid oedema, hyponatraemia, malignant neoplasm progression, malnutrition. Sutent dosage: DAILY DOSE:25MG. Patient was hospitalized. Patient died on 12/01/2007.
Sutent Side Effects Report #5600790-6
Sutent side effect was reported by a Physician from AUSTRALIA on Jan 14, 2008. Female patient, weighting 141.8 lb, was diagnosed with renal cell carcinoma, metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, metastases to bone, nausea
, renal cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with OXYCONTIN. Patient died on 11/10/2007.Sutent Side Effects Report #5614303-6
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2008. Male patient, weighting 165.3 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, fatigue, joint swelling, memory impairment, renal cell carcinoma, respiratory failure. Sutent dosage: unknown. Patient died on 01/01/2008.
Sutent Side Effects Report #5623439-5
Sutent side effect was reported by a Consumer or non-health professional from ARGENTINA on Jan 31, 2008. Male patient, weighting 198.4 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood pressure increased, blood urea increased, dehydration, disease progression, dysgeusia, eczema
, fatigue, renal cell carcinoma, tremor. Sutent dosage: unknown. During the same period patient was treated with ATENOLOL, CLONIDINE W, ENALAPRIL MALEATE, LOPID. Patient was hospitalized. Patient died on 01/19/2008.Sutent Side Effects Report #5628473-7
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2008. Male patient, weighting 200.0 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cardiac arrest
, disease progression, hypercalcaemia, renal cell carcinoma, renal failure acute. Sutent dosage: unknown. Patient died on 01/04/2008.Sutent Side Effects Report #5643733-1
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2008. Female patient, weighting 130.1 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood glucose increased, disease progression, monoplegia, oral infection, renal cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with NORVASC, TENORMIN, LEXAPRO, DILANTIN, DECADRON, VITAMINS. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5657431-1
Sutent side effect was reported by a Physician from AUSTRALIA on Feb 27, 2008. Male patient, weighting 176.4 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: unknown. Patient died.
Sutent Side Effects Report #5664844-0
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Male patient, weighting 285.1 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, disease progression, mucosal inflammation, renal cell carcinoma, wound complication. Sutent dosage: unknown. During the same period patient was treated with ACTOS, NOVOLOG, NORVASC, LASIX, PROTONIX, LISINOPRIL, VYTORIN, LANTUS. Patient was hospitalized. Patient died on 11/02/2005.
Sutent Side Effects Report #5671328-2
Sutent side effect was reported by a Physician from AUSTRALIA on Mar 07, 2008. Male patient, weighting 154.3 lb, was diagnosed with renal cell carcinoma, constipation
, fatigue, wound infection, pain , gastrooesophageal reflux disease, candidiasis and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with MOVICOL, DEXAMETHASONE, VANCOMYCIN, AMITRIPTYLINE, OXYCONTIN, PANTOPRAZOLE, NILSTAT, COLOXYL WITH SENNA. Patient died.Sutent Side Effects Report #5713346-1
Sutent side effect was reported by a Physician from UNITED STATES on Apr 15, 2008. Male patient, weighting 165.3 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anorexia, dehydration, disease progression, fatigue, joint swelling, leukopenia, memory impairment. Sutent dosage: unknown. Patient died on 01/01/2008.
Sutent Side Effects Report #5763006-6
Sutent side effect was reported by a Consumer or non-health professional from AUSTRALIA on May 28, 2008. Female patient, weighting 121.9 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: depressed level of consciousness, disease progression, disseminated intravascular coagulation, liver disorder, melaena, metabolic acidosis, renal cell carcinoma, sepsis
, thrombocytopenia. Sutent dosage: unknown. During the same period patient was treated with OXYNORM, METOCLOPRAMIDE, TRAMADOL, ACETAMINOPHEN. Patient was hospitalized. Patient died on 06/10/2006.Sutent Side Effects Report #5782272-4
Sutent side effect was reported by a Health Professional from UNITED STATES on June 12, 2008. Male patient, weighting 216.1 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: amnesia, disease progression, haemorrhage, perineal pain, rash pruritic, rectal haemorrhage, renal cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, VALSARTAN, ALLOPURINOL, ZOLOFT, TRICOR, MIRALAX, DEXAMETHASONE, DILAUDID. Patient died on 01/09/2008.
Sutent Side Effects Report #5795407-4
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2008. Male patient, weighting 174.2 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anaemia, disease progression, hiccups, lower gastrointestinal haemorrhage, renal cell carcinoma, retroperitoneal abscess. Sutent dosage: unknown. During the same period patient was treated with IBUROFEN, TYLENOL W, LOPERAMIDE HYDROCHLORIDE, REGLAN, NAPROSYN. Patient was hospitalized. Patient died on 06/14/2007.
Sutent Side Effects Report #5806356-7
Sutent side effect was reported by a Physician from UNITED STATES on June 30, 2008. Male patient, weighting 188.1 lb, was diagnosed with renal cell carcinoma, metastases to bone and was treated with Sutent. After drug was administered, patient experienced the following side effects: cellulitis
, disease progression, gastrointestinal haemorrhage, pathological fracture, renal cell carcinoma, skin ulcer. Sutent dosage: unknown. During the same period patient was treated with SORAFENIB TOSILATE. Patient died on 01/30/2008.Sutent Side Effects Report #5830450-8
Sutent side effect was reported by a Physician from UNITED STATES on July 21, 2008. Male patient, weighting 187.4 lb, was diagnosed with renal cell carcinoma, metastases to bone and was treated with Sutent. After drug was administered, patient experienced the following side effects: cellulitis
, disease progression, gastrointestinal haemorrhage, pathological fracture, renal cell carcinoma, skin ulcer. Sutent dosage: unknown. During the same period patient was treated with SORAFENIB TOSILATE. Patient died on 01/30/2008.Sutent Side Effects Report #5867767-7
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2008. Male patient, weighting 165.3 lb, was diagnosed with renal cell carcinoma, metastases to central nervous system, prophylaxis, vitamin supplementation, metastases to lung, pain
, insomnia and was treated with Sutent. After drug was administered, patient experienced the following side effects: abdominal pain , chills, disease progression, diverticulitis, pleural effusion, pyrexia, renal cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with DEXAMETHASONE, LEVETIRACETAM, ASCORBIC ACID, ALBUTEROL, ACETAMINOPHEN, ZOLPIDEM. Patient was hospitalized. Patient died on 03/19/2006.Sutent Side Effects Report #5870181-1
Sutent side effect was reported by a Physician from AUSTRALIA on Aug 26, 2008. Male patient, weighting 163.1 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression. Sutent dosage: unknown. Patient died on 06/27/2008.
Sutent Side Effects Report #5941210-1
Sutent side effect was reported by a Consumer or non-health professional from JAPAN on Oct 23, 2008. Male patient, weighting 123.5 lb, was diagnosed with renal cell carcinoma, gastrooesophageal reflux disease and was treated with Sutent. After drug was administered, patient experienced the following side effects: ascites, disease progression, lymphoma
, renal cell carcinoma. Sutent dosage: DAILY DOSE:50MG-FREQ:DAILY. During the same period patient was treated with OMEPRAL. Patient died on 09/21/2008.Sutent Side Effects Report #5945373-3
Sutent side effect was reported by a Physician from AUSTRALIA on Oct 29, 2008. Female patient, weighting 185.2 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression. Sutent dosage: unknown. Patient died.
Sutent Side Effects Report #5957087-4
Sutent side effect was reported by a Consumer or non-health professional from JAPAN on Nov 06, 2008. Male patient, weighting 132.3 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cardiac disorder, delirium, depressed level of consciousness, depression
, disease progression, disseminated intravascular coagulation, dyspnoea, ejection fraction decreased, haemorrhage. Sutent dosage: DAILY DOSE:37.5MG. During the same period patient was treated with INTERFERON, ATELEC, EXCEGRAN, COLDRIN, CODEINE PHOSPHATE, DEPAS, MAGNESIUM OXIDE. Patient died on 10/21/2008.Sutent Side Effects Report #5969551-2
Sutent side effect was reported by a Consumer or non-health professional from JAPAN on Nov 14, 2008. Male patient, weighting 123.5 lb, was diagnosed with renal cell carcinoma, gastrooesophageal reflux disease and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, lymphoma
, neoplasm malignant, renal cell carcinoma. Sutent dosage: DAILY DOSE:50MG-FREQ:DAILY. During the same period patient was treated with OMEPRAL. Patient died on 09/21/2008.Sutent Side Effects Report #5969724-9
Sutent side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Male patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased, renal cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with NOVAMIN, OXYCONTIN, MICARDIS, TENORMIN, CALONAL, PANTOSIN, MAGNESIUM OXIDE, FENTANYL. Patient died on 10/27/2008.
Sutent Side Effects Report #5971267-3
Sutent side effect was reported by a Consumer or non-health professional from JAPAN on Nov 17, 2008. Male patient, weighting 132.3 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, renal cell carcinoma. Sutent dosage: DAILY DOSE:50MG-FREQ:DAILY. During the same period patient was treated with MOBIC, NOVAMIN, PURSENNID, MYSLEE, OXYCONTIN, MAGNESIUM OXIDE, LAFUTIDINE, LORAZEPAM. Patient died on 09/23/2008.
Sutent Side Effects Report #5974872-3
Sutent side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2008. Male patient, weighting 136.7 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: unknown. During the same period patient was treated with NORVASC, BLOPRESS, CELESTONE, SELENICA, TAKEPRON. Patient died on 11/02/2008.
Sutent Side Effects Report #5999127-2
Sutent side effect was reported by a Physician from AUSTRALIA on Dec 02, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: unknown. Patient recovered.
Sutent Side Effects Report #6013440-4
Sutent side effect was reported by a Physician from AUSTRALIA on Oct 03, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: unknown. Patient recovered.
Sutent Side Effects Report #6019164-1
Sutent side effect was reported by a Physician from CANADA on Dec 16, 2008. Female patient was diagnosed with renal cell carcinoma, pain
and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, pancytopenia, renal cell carcinoma, thrombocytopenia. Sutent dosage: 50 MG, 1X/DAY. During the same period patient was treated with GABAPENTIN, HYDROMORPHONE HYDROCHLORIDE. Patient died on 10/29/2008.Sutent Side Effects Report #6039201-8
Sutent side effect was reported by a Physician from ARGENTINA on Nov 28, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hepatic enzyme, intestinal perforation, jaundice
, renal cell carcinoma. Sutent dosage: 50 MG, 1X/DAY. Patient was hospitalized. Patient died on 11/21/2008.Sutent Side Effects Report #6048061-0
Sutent side effect was reported by a Health Professional from AUSTRALIA on Jan 13, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: 50 MG, 1X/DAY. Patient died.
Sutent Side Effects Report #6051843-2
Sutent side effect was reported by a Physician from CANADA on Dec 16, 2008. Female patient was diagnosed with renal cell carcinoma, pain
and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, pancytopenia, renal cell carcinoma, thrombocytopenia. Sutent dosage: 50 MG, 1X/DAY. During the same period patient was treated with GABAPENTIN, HYDROMORPHONE HYDROCHLORIDE. Patient died on 10/29/2008.Sutent Side Effects Report #6052831-2
Sutent side effect was reported by a Physician from AUSTRALIA on Jan 15, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: unknown. Patient died.
Sutent Side Effects Report #6112689-X
Sutent side effect was reported by a Physician from AUSTRALIA on Feb 19, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: 50 MG, 1X/DAY. Patient died on 01/01/2009.
Sutent Side Effects Report #6137970-X
Sutent side effect was reported by a Physician from AUSTRALIA on Mar 19, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cell carcinoma. Sutent dosage: 25 MG, UNK. Patient was hospitalized. Patient died on 02/08/2009.
Sutent Side Effects Report #5839220-8
Sutent side effect was reported by a Physician from ARGENTINA on July 28, 2008. Female patient, 51 years of age, was diagnosed with renal cancer stage iv and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, electrocardiogram change, hypertension, renal cancer stage iv. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4976295-2
Sutent side effect was reported by a Health Professional from UNITED KINGDOM on Mar 30, 2006. Male patient, 66 years of age, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, fall
, hypoglycaemia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5154540-0
Sutent side effect was reported by a Physician from FRANCE on Oct 30, 2006. Male patient, 52 years of age, weighting 167.6 lb, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: chest pain
, disease progression, dyspnoea, lung disorder, po2 decreased. Sutent dosage: 37.5 MG (37.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, GLUCOPHAGE, ACTOS. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5064490-6
Sutent side effect was reported by a Health Professional from UNITED STATES on July 12, 2006. Male patient, 47 years of age, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: anorexia, disease progression, dyspnoea, fatigue, fluid intake reduced, mobility decreased, pulmonary mass, weight decreased. Sutent dosage: 50 MG, DAILY, ORAL. During the same period patient was treated with VALIUM, OXYCODONE AND ACETAMINOPHEN. Patient died.
Sutent Side Effects Report #5503399-8
Sutent side effect was reported by a Physician from FRANCE on Oct 19, 2007. Male patient, 36 years of age, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal haemorrhage, pneumoperitoneum. Sutent dosage: unknown. Patient recovered.
Sutent Side Effects Report #5486131-6
Sutent side effect was reported by a Physician from FRANCE on Oct 03, 2007. Female patient, weighting 121.3 lb, was diagnosed with renal cancer metastatic, depression
, pain and was treated with Sutent. After drug was administered, patient experienced the following side effects: amenorrhoea, disease progression, renal cancer metastatic. Sutent dosage: unknown. During the same period patient was treated with OMEPRAZOLE, SEROPRAM, SKENAN. Patient died on 01/01/2007.Sutent Side Effects Report #5488722-5
Sutent side effect was reported by a Physician from FRANCE on Oct 09, 2007. Female patient, weighting 121.3 lb, was diagnosed with renal cancer metastatic, depression
, pain and was treated with Sutent. After drug was administered, patient experienced the following side effects: amenorrhoea, disease progression, renal cancer metastatic. Sutent dosage: unknown. During the same period patient was treated with OMEPRAZOLE, SEROPRAM, SKENAN. Patient died on 01/01/2007.Sutent Side Effects Report #5767915-3
Sutent side effect was reported by a Physician from FRANCE on June 03, 2008. Male patient, weighting 134.5 lb, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: anaemia, aortic dissection, chest pain
, disease progression, dry mouth, dysgeusia, nausea , renal cancer metastatic. Sutent dosage: DAILY DOSE:50MG. During the same period patient was treated with NEBIVOLOL. Patient recovered.Sutent Side Effects Report #5802129-X
Sutent side effect was reported by a Consumer or non-health professional from BRAZIL on June 25, 2008. Male patient, weighting 138.9 lb, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, cerebral haemorrhage, convulsion, disease progression, fatigue, nausea
, renal cancer. Sutent dosage: unknown. During the same period patient was treated with EUTHYROX, LASIX, CAPTOPRIL, RIVOTRIL. Patient died on 05/22/2008.Sutent Side Effects Report #5931775-8
Sutent side effect was reported by a Physician from FRANCE on Oct 15, 2008. Male patient, weighting 169.8 lb, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal haemorrhage, gastrointestinal perforation, pneumoperitoneum. Sutent dosage: unknown. Patient died on 10/26/2007.
Sutent Side Effects Report #5839291-9
Sutent side effect was reported by a Physician from UNITED STATES on July 28, 2008. Female patient, 65 years of age, was diagnosed with renal cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: cardiac disorder, colitis, disease progression, ejection fraction decreased, pyrexia, renal cancer, respiratory failure. Sutent dosage: unknown. Patient recovered.
Sutent Side Effects Report #5831394-8
Sutent side effect was reported by a Health Professional from UNITED STATES on July 21, 2008. Male patient, weighting 210.1 lb, was diagnosed with renal cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, dysgeusia, fatigue, hiatus hernia, hypertension, renal cancer. Sutent dosage: unknown. During the same period patient was treated with LIPITOR, OMEPRAZOLE, BENAZEPRIL HYDROCHLORIDE, TRAMADOL, ACETAMINOPHEN. Patient died on 07/01/2008.
Sutent Side Effects Report #6004250-2
Sutent side effect was reported by a Health Professional from UNITED KINGDOM on Dec 04, 2008. Female patient was diagnosed with renal cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, breath sounds abnormal, bronchopneumonia, circulatory collapse, confusional state, disease progression, dyspnoea, gastrooesophageal reflux disease, incontinence. Sutent dosage: unknown. During the same period patient was treated with INTERFERON, DEXAMETHASONE. Patient died on 07/22/2008.
Sutent Side Effects Report #6053016-6
Sutent side effect was reported by a Physician from AUSTRALIA on Jan 15, 2009. Female patient was diagnosed with renal cancer, appetite disorder, depression
, hypertension and was treated with Sutent. After drug was administered, patient experienced the following side effects: appetite disorder, depression , diarrhoea, disease progression, performance status decreased, renal cell carcinoma. Sutent dosage: 50 MG, CYCLIC. During the same period patient was treated with PREDNISOLONE, ZOLOFT, ADALAT, COVERSYL. Patient died on 12/25/2008.Sutent Side Effects Report #6107611-6
Sutent side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Male patient was diagnosed with renal cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, renal cancer. Sutent dosage: 50 MG, DAILY, EVERY DAY. Patient died on 01/15/2009.
Sutent Side Effects Report #5392803-4
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Male patient, weighting 154.1 lb, was diagnosed with prostate cancer
and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood potassium decreased, blood sodium decreased, disease progression, platelet count increased, pneumonia . Sutent dosage: unknown. During the same period patient was treated with RESTORIL, PREVACID, LIPITOR, LORTAB, XANAX, VITAMIN CAP, ROXICODONE, ZITHROMAX. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #6073585-X
Sutent side effect was reported by a Health Professional from BELGIUM on Jan 30, 2009. Female patient was diagnosed with oesophageal carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, disease progression, dyspnoea, pneumonia
, pneumonia aspiration, pulmonary embolism , respiratory failure, somnolence. Sutent dosage: 50 MG, 1X/DAY. During the same period patient was treated with FORLAX, MEDROL, OMEPRAZOLE, DURAGESIC. Patient died on 08/27/2008.Sutent Side Effects Report #5165787-1
Sutent side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2006. Male patient, 74 years of age, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, fatigue, malignant pleural effusion, respiratory disorder, respiratory failure. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL ; 37.5 MG (12.5 MG, 3 IN 1 D), ORAL. During the same period patient was treated with MORPHINE SULPHATE, HYDROCHLOROTHIAZIDE, ATENOLOL. Patient died on 11/11/2005.
Sutent Side Effects Report #5156503-8
Sutent side effect was reported by a Health Professional from UNITED STATES on Oct 28, 2006. Male patient, 68 years of age, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, fatigue, malignant pleural effusion, respiratory failure. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ATENOLOL. Patient was hospitalized. Patient died on 11/11/2005.
Sutent Side Effects Report #4936447-4
Sutent side effect was reported by a Physician from UNITED STATES on Feb 17, 2006. Male patient, 65 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, arrhythmia
, atelectasis, blood pressure systolic increased, bronchostenosis, diastolic dysfunction, disease progression, dyspnoea, fatigue. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TESSALON, OXYCODONE, NEURONTIN, SINGULAIR, PREDNISONE, SCOPOLAMINE. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #4953101-3
Sutent side effect was reported by a Physician from UNITED STATES on Mar 06, 2006. Male patient, 65 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, arrhythmia
, aspiration, atelectasis, bone pain, cardiac disorder, condition aggravated, disease progression, dyspnoea. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TESSALON, OXYCODONE, NEURONTIN, SINGULAIR, PREDNISONE, SCOPOLAMINE. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5367956-4
Sutent side effect was reported by a Physician from BRAZIL on June 11, 2007. Female patient, 58 years of age, was diagnosed with neuroendocrine carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, leukopenia, neuroendocrine carcinoma, thrombocytopenia. Sutent dosage: unknown. Patient was hospitalized. Patient died on 03/01/2007.
Sutent Side Effects Report #5049104-3
Sutent side effect was reported by a Health Professional from GERMANY on June 23, 2006. Female patient, 75 years of age, weighting 134.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anaemia, disease progression, thrombocytopenia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL; SEE IMAGE. During the same period patient was treated with ALFACALCIDOL, LEVOTHYROXINE, SIMVASTATIN, VERAPAMIL, NOVALGIN, CARNIGENTE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5114177-6
Sutent side effect was reported by a Physician from AUSTRALIA on Sept 08, 2006. Male patient, 75 years of age, weighting 177.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: delirium, disease progression, haemoptysis, oral intake reduced. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with NORVASC, LIPITOR, AVAPRO. Patient was hospitalized. Patient died on 09/08/2006.
Sutent Side Effects Report #5176569-9
Sutent side effect was reported by a Health Professional from CANADA on Nov 27, 2006. Male patient, 75 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cerebrovascular accident, disease progression. Sutent dosage: 37.5 MG (37.5 MG,1 IN 1 D), ORAL. During the same period patient was treated with SENOKOT, HYDROMORPHONE. Patient died on 09/29/2006.
Sutent Side Effects Report #5191732-9
Sutent side effect was reported by a Health Professional from CANADA on Dec 06, 2006. Male patient, 75 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cerebrovascular accident, disease progression, metastatic renal cell carcinoma. Sutent dosage: 37.5 MG (37.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SENOKOT, HYDROMORPHONE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5717116-X
Sutent side effect was reported by a Consumer or non-health professional from PERU on Apr 15, 2008. Male patient, 75 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anaemia, blister, discomfort, disease progression, metastatic renal cell carcinoma, nausea
, pain in extremity, renal failure. Sutent dosage: unknown. Patient died on 03/10/2008.Sutent Side Effects Report #5174441-1
Sutent side effect was reported by a Physician from NETHERLANDS on Nov 21, 2006. Female patient, 74 years of age, weighting 121.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, disease progression, fatigue, fracture
, hemiparesis, pyrexia, renal impairment. Sutent dosage: 37.5 MG (37.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, AMLODIPINE. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5131688-8
Sutent side effect was reported by a Physician from BRAZIL on Oct 02, 2006. Male patient, 71 years of age, weighting 180.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, disease progression, metastases to central nervous system. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PHENYTOIN, TRAMADOL, OMEPAZOLE, DECADRON. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5104076-8
Sutent side effect was reported by a Physician from GERMANY on Aug 29, 2006. Male patient, 70 years of age, weighting 136.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, pleural effusion. Sutent dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Sutent Side Effects Report #5018275-7
Sutent side effect was reported by a Physician from GERMANY on May 17, 2006. Male patient, 70 years of age, weighting 136.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, malignant pleural effusion. Sutent dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Sutent Side Effects Report #5189875-9
Sutent side effect was reported by a Health Professional from ITALY on Dec 05, 2006. Male patient, 68 years of age, weighting 112.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, pyrexia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with AMOXICILLIN, EPOETIN BETA. Patient died on 12/03/2006.
Sutent Side Effects Report #5154380-2
Sutent side effect was reported by a Health Professional from BRAZIL on Nov 01, 2006. Male patient, 66 years of age, weighting 152.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anorexia, asthenia, confusional state, disease progression, disorientation, fibrin d dimer increased, leukocytoclastic vasculitis, neurotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SECOTEX, DEXAMETHASONE, CELECOXIB, GLICLAZIDE, FENTANYL, MORPHINE. Patient was hospitalized. Patient died on 04/03/2006.
Sutent Side Effects Report #4947621-5
Sutent side effect was reported by a Physician from GERMANY on Mar 02, 2006. Male patient, 66 years of age, weighting 176.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, vomiting. Sutent dosage: 50 MG ONCE INTERVAL:DAILY ORAL. During the same period patient was treated with TOREM, LEVOFLOXACIN, IBUPROFEN, PANTOPRAZOLE, TRAMADOL. Patient was hospitalized. Patient died on 02/22/2006.
Sutent Side Effects Report #4974478-9
Sutent side effect was reported by a Health Professional from UNITED KINGDOM on Mar 27, 2006. Male patient, 66 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: diabetes mellitus, disease progression, fall
, hypoglycaemia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5012243-7
Sutent side effect was reported by a Physician from UNITED STATES on May 17, 2006. Female patient, 66 years of age, weighting 215.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: dehydration, disease progression, hypersomnia, lethargy, oral intake reduced, syncope. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with INTRON A, POTASSIUM CHLORIDE, PROTONIX, COSAMIN DS, PSYLLIUM, VITAMIN, LASIX, METOLAZONE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5700346-0
Sutent side effect was reported by a Physician from INDIA on Mar 28, 2008. Male patient, 63 years of age, weighting 154.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, disease progression, epistaxis, lung infection, metastatic renal cell carcinoma, oropharyngeal blistering. Sutent dosage: unknown. Patient was hospitalized. Patient died on 02/05/2008.
Sutent Side Effects Report #4999970-2
Sutent side effect was reported by a Physician from SINGAPORE on Apr 19, 2006. Male patient, 63 years of age, weighting 165.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, enteritis, lethargy, performance status decreased, peritonitis bacterial, superinfection. Sutent dosage: 50 MG (50 MG, QD, INTERVAL: DAILY), ORAL. Patient was hospitalized. Patient died on 04/09/2006.
Sutent Side Effects Report #5128257-2
Sutent side effect was reported by a Physician from PORTUGAL on Sept 28, 2006. Female patient, 62 years of age, weighting 83.78 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal haemorrhage, haemoglobin decreased, hiatus hernia, platelet count decreased. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5141066-3
Sutent side effect was reported by a Health Professional from SPAIN on Oct 13, 2006. Male patient, 60 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anorexia, asthenia, disease progression, hypercalcaemia, respiratory tract infection. Sutent dosage: 37.5 MG (37.5 MG, 1 IN 1 D) ORAL. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient died on 06/14/2006.
Sutent Side Effects Report #5044547-6
Sutent side effect was reported by a Physician from GREECE on June 20, 2006. Male patient, 60 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hyponatraemia, urinary retention. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5045849-X
Sutent side effect was reported by a Physician from GREECE on June 20, 2006. Male patient, 60 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hyponatraemia, urinary retention. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5174911-6
Sutent side effect was reported by a Physician from ITALY on Nov 24, 2006. Male patient, 58 years of age, weighting 183.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, ecchymosis. Sutent dosage: 375 MG (12.5 MG, BID: EVERY DAY), ORAL. During the same period patient was treated with LANSOPRAZOLE, TRAMADOL, DOXAZOSIN MESYLATE, VALSARTAN, METHYLPREDNISOLONE, TETRACOSACTIDE, DALTEPARIN, FITOMENADION. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5815363-X
Sutent side effect was reported by a Physician from UNITED STATES on July 08, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, gastrooesophageal reflux disease, haematuria, metastatic renal cell carcinoma, rash
, spinal compression fracture, therapeutic response unexpected, wound infection. Sutent dosage: DAILY DOSE:50MG-FREQ:DAILY. During the same period patient was treated with ZOMETA, MIRALAX, NICOTINE, OMEPRAZOLE, CLINDAMYCIN, TYLENOL, VICODIN, FENTANYL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5018216-2
Sutent side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on May 16, 2006. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: chills, disease progression, disseminated intravascular coagulation, haemoglobin decreased, jaundice
, neutropenia, respiratory failure, thrombocytopenia. Sutent dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, DEXAMETHASONE, MEDICON A. Patient died on 05/19/2006.Sutent Side Effects Report #4998849-X
Sutent side effect was reported by a Physician from UNITED STATES on Apr 27, 2006. Male patient, 55 years of age, weighting 97.00 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disease progression, hypotension, lower gastrointestinal haemorrhage, perirectal abscess, pneumothorax, pulmonary embolism
, pulmonary oedema. Sutent dosage: 25 MG (25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVAQUIN, VICODIN, MORPHINE, NYSTATIN, IMODIUM. Patient was hospitalized. Patient died on 10/11/2005.Sutent Side Effects Report #5012182-1
Sutent side effect was reported by a Physician from UNITED STATES on May 12, 2006. Male patient, 55 years of age, weighting 97.00 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, hypotension, large intestine perforation, lower gastrointestinal haemorrhage, pneumothorax, proctalgia, pulmonary oedema, rectal abscess. Sutent dosage: 25 MG (25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVAQUIN, VICODIN, MORPHINE, NYSTATIN, IMODIUM. Patient was hospitalized. Patient died on 10/11/2005.
Sutent Side Effects Report #5076230-5
Sutent side effect was reported by a Physician from KOREA, REPUBLIC OF on July 24, 2006. Male patient, 51 years of age, weighting 123.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, asthenia, bacterial sepsis, disease progression, escherichia infection, ileus, somnolence. Sutent dosage: 50 MG (50 MG, CYCLIC INTERVAL: EVERYDAY), ORAL. During the same period patient was treated with CARBAMAZEPINE, LAMOTRIGINE, IMIDAPRIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 06/30/2006.Sutent Side Effects Report #5158101-9
Sutent side effect was reported by a Pharmacist from SPAIN on Nov 06, 2006. Female patient, 50 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, metastatic renal cell carcinoma. Sutent dosage: 37.5 MG (37.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with FENTANYL, FUROSEMIDE, DUPHALAC, METAMIZOL, HEPARIN, LORAZEPAM, MORPHINE SULPHATE. Patient died on 10/31/2006.
Sutent Side Effects Report #5266577-1
Sutent side effect was reported by a Health Professional from INDIA on Mar 05, 2007. Male patient, 44 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, metastatic renal cell carcinoma. Sutent dosage: unknown. Patient died on 01/18/2007.
Sutent Side Effects Report #5151873-9
Sutent side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 27, 2006. Male patient, 40 years of age, weighting 115.7 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: ascites, confusional state, disease progression, dyspnoea, incoherent, pleural effusion, pneumothorax, renal failure acute. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient died on 10/27/2006.
Sutent Side Effects Report #5091323-4
Sutent side effect was reported by a Health Professional from BRAZIL on Aug 11, 2006. Male patient, 26 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, neutropenia, pneumomediastinum, purulence, scar
, subcutaneous emphysema, wound dehiscence. Sutent dosage: unknown. During the same period patient was treated with OMEPRAZOLE, BROMOPRIDE, CODEINE, SPARTEINE, HOMATROPINE. Patient was hospitalized. Patient died on 05/05/2006.Sutent Side Effects Report #5007604-6
Sutent side effect was reported by a Health Professional from BRAZIL on May 08, 2006. Male patient, 26 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, necrosis, neutropenia, pneumomediastinum, postoperative thoracic procedure complication, purulent discharge, subcutaneous emphysema, wound dehiscence. Sutent dosage: 50 MG (50 MG DAILY INTERVAL: EVERY DAY), ORAL. During the same period patient was treated with OMEPRAZOLE, BROMOPRIDE, CODEINE, SPARTEINE, HOMATROPINE. Patient was hospitalized. Patient died on 05/05/2006.